Poolbeg Pharma Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-5.71	-5.79	-3.93	-4.69	-3.11
Depreciation & Amortization	0.13	0.11	0.03	0.03	0.02
Loss (Gain) From Sale of Assets	0.26	0.26	-	-	-
Asset Writedown & Restructuring Costs	-	-	0.35	-	-
Stock-Based Compensation	0.71	0.62	0.05	0.43	0.32
Other Operating Activities	-0.31	0.01	-1.11	-0.21	-
Change in Accounts Receivable	0.21	0.15	0.21	-0.46	-0.67
Change in Accounts Payable	-0.13	-0.01	0.02	0.53	0.58
Operating Cash Flow	-4.85	-4.65	-4.38	-4.37	-2.86
Sale (Purchase) of Intangibles	-0.04	-0.13	-0.18	-0.6	-0.11
Other Investing Activities	0.3	0.43	0.53	0.21	-
Investing Cash Flow	0.26	0.3	0.36	-0.39	-0.11
Total Debt Issued	-	-	-	-	0.3
Total Debt Repaid	-	-	-	-	-0.3
Issuance of Common Stock	4.49	-	-	-	30.9
Financing Cash Flow	4.49	-	-	-	30.9
Net Cash Flow	-0.1	-4.35	-4.02	-4.76	27.93
Levered Free Cash Flow	-2.84	-2.64	-3.37	-3.19	-
Unlevered Free Cash Flow	-2.84	-2.64	-3.37	-3.19	-
Change in Working Capital	0.08	0.14	0.23	0.07	-0.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.